SAREPTA THERAPEUTICS, INC. Operating Leases, Rent Expense
SAREPTA THERAPEUTICS, INC. (SRPT) reported Operating Leases, Rent Expense of $7.90 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-02-28
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2014-12-31 was $1.10M, a 8.33% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2014-09-30 was $1.30M, a 30.00% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2014-06-30 was $900.00K, a 28.57% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for the quarter ending 2014-03-31 was $1.10M, a 83.33% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2018 was $7.90M, a 79.55% increase from fiscal 2017.
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2017 was $4.40M, a 21.43% decline from fiscal 2016.
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2016 was $5.60M, a 7.69% increase from fiscal 2015.
- SAREPTA THERAPEUTICS, INC. operating leases, rent expense for fiscal 2015 was $5.20M, a 18.18% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $7.90M 10-K · filed 2019-02-28 | ||||
| 2017-12-31 | $4.40M 10-K · filed 2019-02-28 | ||||
| 2016-12-31 | $5.60M 10-K · filed 2019-02-28 | ||||
| 2015-12-31 | $5.20M 10-K · filed 2018-03-01 | ||||
| 2014-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $2.40M derived: sum of 2 quarters · filed 2017-02-28 | $3.30M derived: sum of 3 quarters · filed 2017-02-28 | $4.40M 10-K · filed 2017-02-28 | |
| 2014-09-30 | $1.30M 10-Q · filed 2014-11-06 | $2.20M derived: sum of 2 quarters · filed 2014-11-06 | $3.30M 10-Q · filed 2014-11-06 | $4.50M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $900.00K 10-Q · filed 2014-08-07 | $2.00M 10-Q · filed 2014-08-07 | $3.20M derived: sum of 3 quarters · filed 2016-02-25 | $4.20M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $1.10M 10-Q · filed 2014-05-08 | $2.30M derived: sum of 2 quarters · filed 2016-02-25 | $3.30M derived: sum of 3 quarters · filed 2016-02-25 | $4.00M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $2.20M derived: sum of 2 quarters · filed 2016-02-25 | $2.90M derived: sum of 3 quarters · filed 2016-02-25 | $3.40M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $1.00M 10-Q · filed 2014-11-06 | $1.70M derived: sum of 2 quarters · filed 2014-11-06 | $2.20M 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | $700.00K 10-Q · filed 2014-08-07 | $1.30M 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $600.00K 10-Q · filed 2014-05-08 | ||||
| 2012-12-31 | $2.60M 10-K · filed 2015-02-26 | $2.55M 10-K · filed 2013-03-15 | |||
| 2011-12-31 | $2.50M 10-K · filed 2014-03-03 | $2.50M 10-K · filed 2013-03-15 | |||
| 2010-12-31 | $1.82M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |